Transformational therapies for
respiratory infection and serious diseases

 

 

 

Transformational therapies for
respiratory infection and serious diseases

PRESENTATION

AIT Therapeutics Transformational Therapies for Lung and Other Infections

PRESS RELEASE

October 03, 2017 – AIT Therapeutics’ Inhaled Nitric Oxide Therapy Granted Orphan Drug Designation by the U.S. Food and Drug Administration for Treating Infections Caused by Nontuberculous Mycobacteria (NTM)